Related Experiment Videos
Follow-up Study after Percutaneous Transluminal Cerebral Angioplasty
1Division of Neurological Endovascular Intervention, Kochi Medical School; Kochi, Japan - morit-koc@umin.ac.jp.
Summary
Percutaneous transluminal cerebral balloon angioplasty (PTCBA) effectively relieved neurological symptoms in patients with significant intracranial artery stenosis. However, restenosis limited the long-term benefits of this procedure.
Area of Science:
- Neurology
- Interventional Cardiology
- Vascular Surgery
Background:
- Cerebrovascular diseases pose significant health risks.
- Stenosis in extra- and intra-cranial arteries can lead to severe neurological events.
- Percutaneous transluminal cerebral balloon angioplasty (PTCBA) is a potential treatment option.
Purpose of the Study:
- To evaluate the safety and efficacy of PTCBA for treating extra- and intra-cranial artery stenosis.
- To investigate the procedural outcomes and long-term results of PTCBA.
Main Methods:
- Eighty haemodynamically significant lesions (>70% stenosis) in 74 symptomatic patients were treated with PTCBA.
- Patients were followed to assess clinical outcomes, including death, stroke, surgery, and restenosis.
- Life-table methods were used to analyze long-term risks.
Main Results:
- Clinical success was achieved in 81% of treated lesions.
- Recurrent neurological symptoms resolved post-procedure.
- The 3-month angiographic restenosis rate was 22%.
- The 2-year risk of death or stroke was 16%; the risk of death, stroke, surgery, or repeated PTCBA was 49%.
Conclusions:
- PTCBA offers a favorable short-term outcome by reducing neurological symptoms.
- Restenosis is a significant factor limiting the long-term efficacy of PTCBA.
- Further research may be needed to improve long-term patency rates.
Related Concept Videos
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...